2017 WMIF | New Targets in Coronary Artery Disease

Moderator: Sekar Kathiresan, MD, Director, Center for Human Genetic Research, MGH; Associate Professor of Medicine, Harvard Medical School
Aarif Khakoo, MD, VP Research, Cardiometabolic Disorders Therapeutic Area Head, Site Head Amgen San Francisco, Amgen
Clive Meanwell, MD, PhD, CEO, The Medicines Company
Paul Ridker, MD, Director, Center for Cardiovascular Disease Prevention, BWH; Eugene Braunwald Professor of Medicine, Harvard Medical School
Craig Sponseller, MD, CMO, Kowa Pharmaceuticals

Cardiovascular trials have a proud history of providing some of the most robust data in evidence-based medicine. However the growing size and complexity of these trials imperils their future. This panel will discuss the design and implementation of clinical studies globally, considering strategies for patient access, leveraging electronic health records and mobile device data, personalized medicine, regulatory implications, cost containment and management of relationships with global service providers.

Видео 2017 WMIF | New Targets in Coronary Artery Disease канала World Medical Innovation Forum